HKLB:LSEHongkong Land Holdings Limited Analysis
Data as of 2026-03-14 - not real-time
$7.41
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Hongkong Land is trading at $7.41, dramatically above its DCF‑derived fair value of roughly $0.94, indicating a severe overvaluation. Technical indicators reinforce this view: the RSI is at an extreme 100, the 20‑day, 50‑day and 200‑day SMAs all converge on the current price, and the trend is marked as bearish. Fundamentally, the company posted a negative trailing EPS of –$0.15 and a sizable free‑cash‑flow deficit of $‑1.76 bn, while carrying a staggering debt‑to‑equity ratio of 19.9, far outweighing its $2.55 bn cash balance. The profit margin appears high at 87 % on paper, yet the operating margin is only 2.2 % and the net profit margin is negative, reflecting earnings pressure. Liquidity is modest with stable but low volume, and beta is low at 0.26, suggesting limited price volatility but not shielding from fundamental weakness.
Given the combination of overbought technicals, weak earnings, massive leverage, and a DCF gap, the outlook remains challenging across horizons, and any upside would require a material improvement in cash generation or a strategic asset disposition.
Given the combination of overbought technicals, weak earnings, massive leverage, and a DCF gap, the outlook remains challenging across horizons, and any upside would require a material improvement in cash generation or a strategic asset disposition.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 8/10
Key Factors
- RSI at 100 indicates extreme overbought conditions
- Current price far exceeds DCF fair value
- Negative EPS and free cash flow highlight earnings weakness
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Debt‑to‑equity ratio near 20 suggests leverage risk
- Potential asset sales or restructuring could improve balance sheet
- Market sentiment may remain volatile amid regional property cycles
Long Term
> 3 yearsCautious
Model confidence: 6/10
Key Factors
- Sustained high leverage without cash‑flow recovery
- Uncertain recovery in Asian real‑estate markets
- Fundamental misalignment between price and intrinsic value
Key Metrics & Analysis
Financial Health
Revenue Growth-32.30%
Profit Margin87.23%
ROE4.16%
ROA0.49%
Debt/Equity19.92
P/B Ratio0.5
Op. Cash Flow$584.4M
Free Cash Flow$-1760000000
Technical Analysis
TrendBearish
RSI100.0
Support$7.41
Resistance$7.41
MA 20$7.41
MA 50$7.41
MA 200$7.41
MACDNeutral
VolumeStable
Fear & Greed Index72.88
Valuation
Fair Value$0.94
GradeOvervalued
TypeValue
Risk Assessment
00
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.